Implementing robust amyloid PET quantification in multi‐center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges

Abstract INTRODUCTION Amyloid‐positron emission tomography (PET) is pivotal to Alzheimer's management, with the Centiloid standardizing measurements across tracers. AMYPAD trials (Diagnostic and Patient Management Study [DPMS] and Prognostic and Natural History Study [PNHS]) aimed to validate robust...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Ariane Bollack, Mahnaz Shekari, Lyduine E. Collij, Emma Luckett, David Valléz García, Pawel Markiewicz, Robin Wolz, Maqsood Yaqub, Alle Meije Wink, Rossella Gismondi, Andrew Stephens, Pieter Jelle Visser, Anja Mett, Alexander Drzezga, Christopher Buckley, Juan Domingo Gispert, Gill Farrar, Frederik Barkhof
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Wiley 2025-10-01
سلاسل:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
الموضوعات:	Alzheimer's amyloid Centiloid PET quantification
الوصول للمادة أونلاين:	https://doi.org/10.1002/trc2.70190
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!